At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.

CARY, N.C., Aug. 25, 2025 /PRNewswire/ -- WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the launch of WCG Total Training, the ...

Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...

| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...

In the past few years, the healthcare world has faced some of its toughest challenges the COVID-19 pandemic was a wake up call for everyone especially for those involved in clinical trials many trials ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

The COVID-19 pandemic is halting and slowing down clinical trials, and the Food and Drug Administration is offering guidelines to adjust to these new challenges. Clinical trials may slow, stop or ...

The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for ...

Napo Obtains IRB Approval For Phase 3 Clinical Trial Protocol For Crofelemer In HIV/AIDS Diarrhea Assessment Napo Pharmaceuticals, Inc. announces today that it has received approval from the principal ...

SHELTON, CT / ACCESS Newswire / July 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...

Over the past several years, the number of deviations and substantial amendments made to clinical trial protocols has increased notably, contributing to delays in drug development and rising costs for ...